Horizons 2017: Philip E. Wolfson, MD—“Ketamine-Assisted Psychotherapy and the Ketamine Opportunity”

Ketamine-Assisted Psychotherapy is a breakthrough modality for the experiential treatment of many humans and many emotional, spiritual and community difficulties. Within the diagnostic framework this includes depression, suicidality, treatment resistant depression, PTSD, Bipolar 2, OCD, menstrual emotional symptoms, relationship and existential crises. While MDMA and psilocybin therapies are approaching Phase 3 studies and may become prescription medicines in 2021 or later, ketamine stands out as a profound experience that we administer in two formats-as trance and transformation. Spreading widely in clinics administering ketamine by anesthesiologists and psychiatrists in a medicalized intravenous drug format, ketamine’s potential as a liberating agent when presented in a psychotherapeutic format is of superior and enduring merit and leads to awakening mind for many. PHILIP E. WOLFSON, M.D. Psychiatrist, psychotherapist, and Principal Investigator, MAPS MDMA-Assisted Psychotherapy for Anxiety Associated with Life-Threatening Illness Study